I use frontier AI models to explore drug discovery and therapeutic concept design. My background is 30 years in software development, data systems and AI delivery. I now map that systems-engineering experience onto biology: treating disease as failures in signalling, feedback, state transition and repair logic. My work uses models such as ChatGPT, Claude and Gemini to analyse incumbent drugs, expose biological trade-offs, and generate testable therapeutic hypotheses. Current areas include obesity therapeutics, cancer-state resolution, inflammation, fibrosis and tissue repair. I am looking to collaborate with scientists, clinicians, biotech teams, pharma partners and investors to stress-test concepts and move the strongest toward experimental validation.